Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 422

  • Showing results for van biesen. Search instead for Jan Diesend (2 items)
1.

The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.

Gielis EM, Ledeganck KJ, Dendooven A, Meysman P, Beirnaert C, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D.

Nephrol Dial Transplant. 2019 May 18. pii: gfz091. doi: 10.1093/ndt/gfz091. [Epub ahead of print]

PMID:
31106364
2.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Biol Blood Marrow Transplant. 2019 May 6. pii: S1083-8791(19)30286-1. doi: 10.1016/j.bbmt.2019.05.002. [Epub ahead of print]

PMID:
31071457
3.

A swan song for Kt/Vurea.

Vanholder R, Van Biesen W, Lameire N.

Semin Dial. 2019 Apr 25. doi: 10.1111/sdi.12811. [Epub ahead of print] Review.

PMID:
31025455
4.

Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.

Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Godefroid N, Krid S, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Van Dyck M, Van Hoeck K, Collard L, Eloot S, Shroff R.

Toxins (Basel). 2019 Apr 24;11(4). pii: E235. doi: 10.3390/toxins11040235.

5.

Increasing access to integrated ESKD care as part of universal health coverage.

Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O'Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit.

Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005. Review.

PMID:
30904051
6.

Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.

Vanommeslaeghe F, De Somer F, Josipovic I, Boone M, Dhondt A, Van Biesen W, Eloot S.

Artif Organs. 2019 Feb 28. doi: 10.1111/aor.13452. [Epub ahead of print]

PMID:
30820962
7.

A systematic review of patient participation during bedside handovers on wards with older patients indicates evidence is urgently needed.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Int J Older People Nurs. 2019 Feb 15:e12226. doi: 10.1111/opn.12226. [Epub ahead of print] No abstract available.

8.

Enhanced Removal of Protein-Bound Uremic Toxins Using Displacers: Road to Success?

Van Biesen W, Eloot S.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):324-326. doi: 10.2215/CJN.00500119. Epub 2019 Feb 6. No abstract available.

PMID:
30728168
9.

Reporting of "dialysis adequacy" as an outcome in randomised trials conducted in adults on haemodialysis.

Steyaert S, Holvoet E, Nagler E, Malfait S, Van Biesen W.

PLoS One. 2019 Feb 5;14(2):e0207045. doi: 10.1371/journal.pone.0207045. eCollection 2019.

10.

Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative.

INTEGRATED group consists of (in alphabetical order), Chan C, Combes G, Davies S, Finkelstein F, Firanek C, Gomez R, Jager KJ, George VJ, Johnson DW, Lambie M, Madero M, Masakane I, McDonald S, Misra M, Mitra S, Moraes T, Nadeau-Fredette AC, Mukhopadhyay P, Perl J, Pisoni R, Robinson B, Ryu DR, Saran R, Sloand J, Sukul N, Tong A, Szeto CC, Van Biesen W.

Perit Dial Int. 2019 Jan-Feb;39(1):4-12. doi: 10.3747/pdi.2017.00242. Review.

PMID:
30692232
11.

The effectiveness of bedside handovers: A multilevel, longitudinal study of effects on nurses and patients.

Malfait S, Eeckloo K, Van Biesen W, Van Hecke A.

J Adv Nurs. 2019 Jan 21. doi: 10.1111/jan.13954. [Epub ahead of print]

PMID:
30666713
12.

Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.

Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R.

Int Urol Nephrol. 2019 Feb;51(2):293-302. doi: 10.1007/s11255-018-2056-x. Epub 2019 Jan 2.

PMID:
30604232
13.

Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group.

Verberne WR, Das-Gupta Z, Allegretti AS, Bart HAJ, van Biesen W, García-García G, Gibbons E, Parra E, Hemmelder MH, Jager KJ, Ketteler M, Roberts C, Al Rohani M, Salt MJ, Stopper A, Terkivatan T, Tuttle KR, Yang CW, Wheeler DC, Bos WJW.

Am J Kidney Dis. 2019 Mar;73(3):372-384. doi: 10.1053/j.ajkd.2018.10.007. Epub 2018 Dec 20.

14.

An International Analysis of Dialysis Services Reimbursement.

van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):84-93. doi: 10.2215/CJN.08150718. Epub 2018 Dec 13.

PMID:
30545819
15.

Subclinical AKI: ready for primetime in clinical practice?

Vanmassenhove J, Van Biesen W, Vanholder R, Lameire N.

J Nephrol. 2019 Feb;32(1):9-16. doi: 10.1007/s40620-018-00566-y. Epub 2018 Dec 6. Review.

PMID:
30523562
16.

Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.

Gielis EM, Beirnaert C, Dendooven A, Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D, Ledeganck KJ.

PLoS One. 2018 Dec 6;13(12):e0208207. doi: 10.1371/journal.pone.0208207. eCollection 2018.

17.

The Potential Impact of Hydrocarbons on Mussels in Port au Port Bay, Newfoundland.

Cook MC, May A, Kohl L, Van Biesen G, Parrish CC, Morrill PL.

Adv Mar Biol. 2018;81:1-22. doi: 10.1016/bs.amb.2018.09.003. Epub 2018 Oct 15.

PMID:
30471654
18.

Gut microbiota dynamics and uraemic toxins: one size does not fit all.

Joossens M, Faust K, Gryp T, Nguyen ATL, Wang J, Eloot S, Schepers E, Dhondt A, Pletinck A, Vieira-Silva S, Falony G, Vaneechoutte M, Vanholder R, Van Biesen W, Huys GRB, Raes J, Glorieux G.

Gut. 2018 Nov 21. pii: gutjnl-2018-317561. doi: 10.1136/gutjnl-2018-317561. [Epub ahead of print] No abstract available.

19.

Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic model.

Pletinck A, Van Biesen W, Dequidt C, Eloot S.

BMC Nephrol. 2018 Oct 29;19(1):299. doi: 10.1186/s12882-018-1104-1.

20.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959

Supplemental Content

Loading ...
Support Center